Long-Term Survival of PD-1 Inhibitor Combined with Antiangiogenic Agents in a Patient with Pulmonary Sarcomatoid Carcinoma Complicated with Esophageal Cancer: A Case Resport and Literature ReviewShuyue Jiao, Hong Tang, Shaomei Li et al.|Research Square|2021Cited by 0
Significant benefit of high-dose furmonertinib in the treatment of leptomeningeal metastases from non-small-cell lung cancer with EGFR ex19Del mutation: Two case reports and a literature reviewHuan Han, Hong Tang, xiao Zhang et al.|Research Square|2023Cited by 0